Lecanemab Homecare Service
Value
£816,000
Classifications
- Pharmacy services
Tags
- tender
Submission Deadline
1 month from now
Published
3 days ago
Description
Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
Aaron Monaghan
Timeline active
Evaluate
Award
Complete